• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    Codexis, Inc. (CDXS)

    -NasdaqGS
    3.91 Down 0.22(5.33%) 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Codexis, Inc.
    200 Penobscot Drive
    Redwood City, CA 94063
    United States - Map
    Phone: 650-421-8100
    Website: http://www.codexis.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:91

    Business Summary 

    Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. It also provides enzyme screening services and enzyme optimization services; and supplies enzymes, pharmaceutical intermediates, and active pharmaceutical ingredients. In addition, the company develops biocatalysts for use in the fine chemicals market, including food, animal feed, agricultural chemicals, and flavors and fragrances. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Codexis, Inc.

    Corporate Governance 
    Codexis, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 10. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 10; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. John J. Nicols , 51
    Chief Exec. Officer, Pres and Director
    1.01M0.00
    Mr. Gordon T. B. Sangster , 62
    Chief Financial Officer and Sr. VP
    221.00K0.00
    Mr. Douglas T. Sheehy J.D., 48
    Chief Admin. Officer, Exec. VP, Gen. Counsel and Sec.
    575.00K0.00
    Dr. James Lalonde Ph.D., 54
    Sr. VP of R&D
    352.00K39.00K
    Mr. David McCaman , 57
    VP and Corp. Controller
    205.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders